The phase 2 obesity study included a NAFLD substudy, which sought to evaluate how the use of retatrutide in patients with obesity and NAFLD would affect the amount of fat in the liver
The study looked at data from a long period of time from a large number of patients more than 23,000 in all which represents an important step in demonstrating the effectiveness of these drugs, said Prof
AMID THE TALK on GLP-1 benefits, theres also been considerable chatter on its side effects
ESC Heart Failure 11(2):649661 Jalil JE, Gabrielli L, Ocaranza MP, MacNab P, Fernndez R, Grassi B, Jofr P, Verdejo H, Acevedo M, Cordova S et al (2024) New mechanisms to prevent heart failure with preserved ejection fraction using glucagon-like peptide-1 receptor agonism (GLP-1 RA) in metabolic syndrome and in type 2 diabetes: a review